Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study-Reference-Cited by-同舟云学术

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study

Published:2020-05 Issue:5 Volume:11 Page:e00177
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:Clinical and Translational Gastroenterology

Author:

Barberio Brigida,Zingone Fabiana,D'Incà Renata,Rovigo Laura,Bertani Lorenzo,Bodini Giorgia,Ghisa Matteo,Gubbiotti Alessandro,Massimi Davide,Lorenzon Greta,Savarino Edoardo Vincenzo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference25 articles.

1. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects;Allez;J Crohns Colitis,2010

2. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current management;Harbord;J Crohns Colitis,2017

3. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: Surgical management and special situations;Gionchetti;J Crohns Colitis,2016

4. Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-Alpha antibodies;Beigel;PLoS One,2014

5. Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease;Peyrin-Biroulet;J Crohns Colitis,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TNFα in inflammatory bowel disease: from originators to biosimilars;Frontiers in Pharmacology;2024-07-24

2. Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta‐analysis;Health Science Reports;2024-07

3. Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn’s Disease;Journal of Clinical Medicine;2024-03-07

4. Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review;Advances in Therapy;2023-03-17

5. Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis;ClinicoEconomics and Outcomes Research;2023-02